Clinical Trial Update: A One-year, Open Label Study to Investigate the Safety and the Effect of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion in de Novo Kidney Transplant Recipients. [Phase 4]

View source ↗

Summary

Open-label Phase 4 study assessing the safety and effects of enteric-coated mycophenolate sodium in combination with cyclosporine microemulsion in de novo kidne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Enteric-coated mycophenolate sodium (mycophenolate sodium)
• cyclosporine microemulsion (cyclosporine)

Snippet

Sponsor: Novartis | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED